As a result, our findings that show resveratrol can decrease inflammation in placenta and adipose tissue and increase insulin sensitivity in skeletal muscle induced by infection and sterile inflammation remains to be of particular interest as a potential therapeutic in the prevention or management of GDM and/or obesity. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.